Skip to main content
Neurocrine Biosciences, Inc.SEC 8-K

Neurocrine appoints Dr. Eiry Roberts as new Chief Medical Officer, effective September 28, 2026

What happened

3 signals in this filing. The 'mutually agreed' departure of the former CMO, Dr.

Source

Extracted by Autobound

From the Signal API record
Signal
SEC 8-K

What this signalsFilings often name leadership changes, deals and spending plans.

Form
8-K
Filed
Sep 28, 2026

The full record

From the Signal API record

Numbers

Dollar figureTotal target value of new equity grants (options, RSUs, performance units) for the incoming Chief Medical Officer.
$1.3M
PercentTarget annual cash incentive bonus as a percentage of base pay for the new Chief Medical Officer.
0.6%

Details

CIK
914475
Accession number
0000914475-26-000045
Timeframe
Immediate
Filing year
2026
Fiscal year end
09/25
Why it matters
Clinical/R&D vendor review
Signal category
Leadership

Topics and mentions

Events in the filing

  • Chief medical officer change
  • Governance change
  • Restructuring

Tags

  • chiefMedicalOfficerChange
  • governanceChange
  • restructuring

Extraction

Confidence
High
Relevance
100%
Sentiment
Neutral
Detected
Sep 29, 2026
signal_type
sec-8k
signal_subtype
chiefMedicalOfficerChange

Use this data

Get every SEC 8-K signal for Neurocrine Biosciences, Inc. and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Neurocrine Biosciences, Inc. this week?”

  2. Send it to your own tools

    The Signal API returns SEC 8-K signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-8k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/9855ec3b-fb37-415c-bba6-5a54e3710eab returns this record as JSON. POST /v1/companies/enrich returns every signal for neurocrine.com.

{
  "signal_id": "9855ec3b-fb37-415c-bba6-5a54e3710eab",
  "signal_type": "sec-8k",
  "signal_subtype": "chiefMedicalOfficerChange",
  "detected_at": "2026-09-29T08:10:50.006+00:00",
  "company": {
    "name": "Neurocrine Biosciences, Inc.",
    "domain": "neurocrine.com"
  },
  "data": {
    "detail": "The appointment of a new Chief Medical Officer signals a potential shift in clinical development strategy and creates a 90-day window for vendors to engage new leadership. Existing clinical trial, data management, and medical affairs vendor relationships will likely be reviewed.",
    "metrics": {
      "pct": 0.6,
      "timeframe": "immediate",
      "pct_context": "Target annual cash incentive bonus as a percentage of base pay for the new Chief Medical Officer.",
      "dollar_context": "Total target value of new equity grants (options, RSUs, performance units) for the incoming Chief Medical Officer.",
      "dollar_millions": 1.25
    },
    "summary": "Neurocrine appoints Dr. Eiry Roberts as new Chief Medical Officer, effective September 28, 2026",
    "relevance": 1,
    "sentiment": "neutral",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/914475/000091447526000045/nbix-20260925.htm",
    "filing_date": "2026-09-28",
    "filing_year": 2026,
    "fiscal_year_end": "09/25",
    "sales_relevance": "Clinical/R&D vendor review",
    "signal_category": "leadership"
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.